Destination Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$604K Sell
7,723
-78
-1% -$6.1K 0.02% 160
2025
Q1
$565K Sell
7,801
-92
-1% -$6.67K 0.02% 158
2024
Q4
$584K Buy
7,893
+881
+13% +$65.2K 0.02% 149
2024
Q3
$463K Buy
7,012
+193
+3% +$12.7K 0.01% 163
2024
Q2
$630K Sell
6,819
-238
-3% -$22K 0.02% 139
2024
Q1
$674K Sell
7,057
-401
-5% -$38.3K 0.02% 132
2023
Q4
$569K Sell
7,458
-1,678
-18% -$128K 0.02% 144
2023
Q3
$633K Sell
9,136
-101
-1% -$7K 0.02% 136
2023
Q2
$871K Sell
9,237
-420
-4% -$39.6K 0.03% 122
2023
Q1
$799K Buy
9,657
+755
+8% +$62.5K 0.03% 124
2022
Q4
$664K Buy
8,902
+52
+0.6% +$3.88K 0.03% 132
2022
Q3
$731K Buy
8,850
+25
+0.3% +$2.07K 0.03% 119
2022
Q2
$839K Buy
8,825
+1,234
+16% +$117K 0.03% 122
2022
Q1
$894K Sell
7,591
-164
-2% -$19.3K 0.03% 114
2021
Q4
$1.01M Sell
7,755
-13
-0.2% -$1.69K 0.04% 118
2021
Q3
$879K Buy
7,768
+204
+3% +$23.1K 0.03% 112
2021
Q2
$783K Sell
7,564
-54
-0.7% -$5.59K 0.03% 114
2021
Q1
$637K Sell
7,618
-137
-2% -$11.5K 0.03% 120
2020
Q4
$707K Sell
7,755
-425
-5% -$38.7K 0.03% 113
2020
Q3
$653K Sell
8,180
-2,151
-21% -$172K 0.03% 105
2020
Q2
$714K Sell
10,331
-943
-8% -$65.2K 0.04% 101
2020
Q1
$709K Sell
11,274
-249
-2% -$15.7K 0.04% 110
2019
Q4
$896K Buy
11,523
+285
+3% +$22.2K 0.05% 95
2019
Q3
$824K Sell
11,238
-1,956
-15% -$143K 0.04% 94
2019
Q2
$812K Buy
13,194
+2,637
+25% +$162K 0.04% 99
2019
Q1
$673K Buy
10,557
+132
+1% +$8.42K 0.04% 107
2018
Q4
$532K Buy
10,425
+5,856
+128% +$299K 0.03% 108
2018
Q3
$265K Buy
4,569
+4,377
+2,280% +$254K 0.01% 138
2018
Q2
$9K Sell
192
-7,779
-98% -$365K ﹤0.01% 402
2018
Q1
$56K Buy
+7,971
New +$56K ﹤0.01% 237